康宁杰瑞制药-B午后涨超7% 公司再次宣布回购 最高不超过3000万港元

Core Viewpoint - 康宁杰瑞制药-B (09966) announced a share buyback program, indicating confidence in its business outlook and intrinsic value, with a maximum repurchase amount of 30 million HKD [1] Group 1: Share Buyback Announcement - The board of 康宁杰瑞制药 decided on November 7 to repurchase ordinary shares from the open market, with a maximum amount of 30 million HKD [1] - The board believes that the current trading price does not accurately reflect the company's intrinsic value [1] - This buyback is expected to benefit the company and create value for its shareholders [1] Group 2: Previous Buyback Program - In October, 康宁杰瑞制药 announced a plan to repurchase up to 20 million HKD worth of shares [1]